Trial · NCT02512042
Adverse events130
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 130
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Palpitations | Cardiac disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 1 | 489 | 1 |
| other | Palpitations | Cardiac disorders | Azopt® 1% Ophthalmic Suspension | 0 | 475 | 0 |
| other | Sinus bradycardia | Cardiac disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 1 | 489 | 1 |
| other | Sinus bradycardia | Cardiac disorders | Azopt® 1% Ophthalmic Suspension | 0 | 475 | 0 |
| other | Asthenopia | Eye disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 1 | 489 | 1 |
| other | Asthenopia | Eye disorders | Azopt® 1% Ophthalmic Suspension | 1 | 475 | 1 |
| other | Blepharospasm | Eye disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 0 | 489 | 0 |
| other | Blepharospasm | Eye disorders | Azopt® 1% Ophthalmic Suspension | 1 | 475 | 1 |
| other | Cataract nuclear | Eye disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 1 | 489 | 1 |
| other | Cataract nuclear | Eye disorders | Azopt® 1% Ophthalmic Suspension | 0 | 475 | 0 |
| other | Chalazion | Eye disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 1 | 489 | 1 |
| other | Chalazion | Eye disorders | Azopt® 1% Ophthalmic Suspension | 0 | 475 | 0 |
| other | Conjunctival disorder | Eye disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 0 | 489 | 0 |
| other | Conjunctival disorder | Eye disorders | Azopt® 1% Ophthalmic Suspension | 1 | 475 | 1 |
| other | Conjunctival haemorrhage | Eye disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 1 | 489 | 1 |
| other | Conjunctival haemorrhage | Eye disorders | Azopt® 1% Ophthalmic Suspension | 0 | 475 | 0 |
| other | Conjunctival hyperaemia | Eye disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 1 | 489 | 1 |
| other | Conjunctival hyperaemia | Eye disorders | Azopt® 1% Ophthalmic Suspension | 1 | 475 | 1 |
| other | Dry eye | Eye disorders | Generic Brinzolamide 1% Ophthalmic Suspension | 5 | 489 | 5 |
| other | Dry eye | Eye disorders | Azopt® 1% Ophthalmic Suspension | 2 | 475 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02512042/events